Daré Bioscience, Inc.DARENASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
27847.53%
↑ 228% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-21762.42%
Historical baseline
PeriodValueYoY Change
TTM27847.53%+111.6%
2024-239259.61%-21782.1%
2023-1093.40%-248.6%
2022-313.61%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%+100.0%
2016-4805.09%-